China National Biotec Group
-
{
- All
- News
'China National Biotec Group' - 1 News Result(s)
-
50,000 People Globally Part Of Phase 3 Trial Of Chinese COVID-19 Vaccine
Around 50,000 people, across a number of countries, are participating in phase 3 clinical trials of a COVID vaccine developed by the China National Biotec Group (CNBG), the company said on Saturday in a press release.
'China National Biotec Group' - 1 News Result(s)
-
50,000 People Globally Part Of Phase 3 Trial Of Chinese COVID-19 Vaccine
Around 50,000 people, across a number of countries, are participating in phase 3 clinical trials of a COVID vaccine developed by the China National Biotec Group (CNBG), the company said on Saturday in a press release.
